TITLE

HIV-1 RNA May Decline More Slowly in Semen than in Blood following Initiation of Efavirenz-Based Antiretroviral Therapy

AUTHOR(S)
Graham, Susan M.; Holte, Sarah E.; Dragavon, Joan A.; Ramko, Kelly M.; Mandaliya, Kishor N.; McClelland, R. Scott; Peshu, Norbert M.; Sanders, Eduard J.; Krieger, John N.; Coombs, Robert W.; Lama, Javier R.
PUB. DATE
August 2012
SOURCE
PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Antiretroviral therapy (ART) decreases HIV-1 RNA levels in semen and reduces sexual transmission from HIV-1- infected men. Our objective was to study the time course and magnitude of seminal HIV-1 RNA decay after initiation of efavirenz-based ART among 13 antiretroviral-naïve Kenyan men. Methods:HIV-1 RNA was quantified (lower limit of detection, 120 copies/mL) in blood and semen at baseline and over the first month of ART. Median log10 HIV-1 RNA was compared at each time-point using Wilcoxon Signed Rank tests. Perelson's two-phase viral decay model and nonlinear random effects were used to compare decay rates in blood and semen. Results: Median baseline HIV-1 RNA was 4.40 log10 copies/mL in blood (range, 3.20-5.08 log10 copies/mL) and 3.69 log10 copies/mL in semen (range, ,2.08-4.90 log10 copies/mL). The median reduction in HIV-1 RNA by day 28 was 1.90 log10 copies/mL in blood (range, 0.56-2.68 log10 copies/mL) and 1.36 log10 copies/mL in semen (range, 0-2.66 log10 copies/mL). ART led to a decrease from baseline by day 7 in blood and day 14 in semen (p = 0.005 and p = 0.006, respectively). The initial modeled decay rate was slower in semen than in blood (p = 0.06). There was no difference in second-phase decay rates between blood and semen. Conclusions: Efavirenz-based ART reduced HIV-1 RNA levels more slowly in semen than in blood. Although this difference was of borderline significance in this small study, our observations suggest that there is suboptimal suppression of seminal HIV-1 RNA for some men in the early weeks of treatment.
ACCESSION #
80434833

 

Related Articles

  • Plasma and Intracellular Antiretroviral Concentrations in HIV-Infected Patients under Short Cycles of Antiretroviral Therapy. Zehnacker, Laura; Abe, Emuri; Mathez, Dominique; Alvarez, Jean-Claude; Leibowitch, Jacques; Azoulay, Stéphane // AIDS Research & Treatment;2014, p1 

    Study of plasma and intracellular concentrations of atazanavir, lopinavir, nevirapine, and efavirenz was conducted on 48 patients under short cycles of antiretroviral therapy. Intracellular concentrations (IC) were still measurable for all drugs after 85 h or 110 h drug intake despite the...

  • Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural Tanzania. Johannessen, Asgeir; Garrido, Carolina; Zahonero, Natalia; Sandvik, Leiv; Naman, Ezra; Kivuyo, Sokoine L.; Kasubi, Mabula J.; Gundersen, Svein G.; Bruun, Johan N.; de Mendoza, Carmen // Clinical Infectious Diseases;9/15/2009, Vol. 49 Issue 6, p976 

    Background. Monitoring of antiretroviral treatment (ART) with human immunodeficiency virus (HIV) viral loads, as recommended in industrialized countries, is rarely available in resource-limited settings because of the high costs and stringent requirements for storage and transport of plasma....

  • Are All Subtypes Created Equal? The Effectiveness of Antiretroviral Therapy against Non-Subtype B HIV-1. Pond, Sergei L. Kosakovsky; Smith, Davey M. // Clinical Infectious Diseases;5/1/2009, Vol. 48 Issue 9, p1306 

    The article reports on the study regarding the effectiveness of modern combination of antiretroviral therapy against non-subtype B HIV-1 in the U.S. It states that the study examined the rates of viral suppression with antiretroviral therapy during infection with subtypes A, C, and D and with...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Transmission of HIV-1 infection due to a fist fight. Emerson, C. R.; Quah, S. P. // International Journal of STD & AIDS;Feb2008, Vol. 19 Issue 2, p131 

    We report a case of HIV-1 infection transmission caused by a fist fight between brothers. A 30-year-old Caucasian UK resident man developed 'flu-like illness with symptoms of lethargy and weakness. Persistent lymphadenopathy six months later lead to HIV antibody testing, which was positive. Of...

  • Colon Exam Finds Possible Trouble Spots in 60% With HIV.  // HIV Treatment ALERTS!;Apr2012, p24 

    The article presents a study which aims to assess colonoscopy rates in HIV-positive people. It mentions that people with abnormal colon cell results in laboratory studies did not differ from those with normal colon cell results in gender, age, HIV transmission risk, years of antiretroviral...

  • The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection. Calitri, Carmelina; Gabiano, Clara; Galli, Luisa; Chiappini, Elena; Giaquinto, Carlo; Buffolano, Wilma; Genovese, Orazio; Esposito, Susanna; Bernardi, Stefania; De Martino, Maurizio; Tovo, Pier-Angelo // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background In the Highly Active Antiretroviral Therapy (HAART) era, the prognosis of children perinatally infected with HIV-1 has significantly improved, so the number of perinatallyinfected females entering child-bearing age and experiencing motherhood is increasing. Methods A description of...

  • PARTNER: Low risk for HIV transmission through unprotected sex.  // Infectious Disease News;Apr2014, Vol. 27 Issue 4, p38 

    The article discusses a study, led by Jens Lundgren and presented at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, Massachusetts, which suggests that an HIV-positive person on antiretroviral therapy (ART) with suppressed viral load is not sexually infectious.

  • HIV breakthrough.  // New Scientist;5/21/2011, Vol. 210 Issue 2813, p5 

    The article discusses results of a study that suggests antiretroviral therapy (ART) given to HIV-positive individuals before they developed symptoms did not seem to spread the virus to their uninfected partners.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics